138 related articles for article (PubMed ID: 33777357)
1. An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity.
Hossain MI; Thomas AG; Mahdi F; Adam AT; Akins NS; Woodard MM; Paris JJ; Slusher BS; Le HV
RSC Adv; 2021 Feb; 11(13):7115-7128. PubMed ID: 33777357
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of tert-butyl ester and ethyl ester prodrugs of L-γ-methyleneglutamic acid amides for cancer.
Khan MIH; Mahdi F; Penfornis P; Akins NS; Hossain MI; Kim SJ; Sulochana SP; Adam AT; Tran TD; Tan C; Paolo Claudio P; Paris JJ; Le HV
Bioorg Med Chem; 2023 Jan; 78():117137. PubMed ID: 36603398
[TBL] [Abstract][Full Text] [Related]
3. A new amino acid amide in the groundnut plant (Arachis hypogaea); evidence of the occurrence of gamma-methyleneglutamine and gamma-methyleneglutamic acid.
DONE J; FOWDEN L
Biochem J; 1952 Jul; 51(4):451-8. PubMed ID: 13018102
[No Abstract] [Full Text] [Related]
4. 4-methyleneglutamine in peanut plants: dynamics of formation, levels, and turnover in relation to other free amino acids.
Winter HC; Powell GK; Dekker EE
Plant Physiol; 1981 Sep; 68(3):588-93. PubMed ID: 16661962
[TBL] [Abstract][Full Text] [Related]
5. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.
Wiebe JP; Lewis MJ
BMC Cancer; 2003 Mar; 3():9. PubMed ID: 12659654
[TBL] [Abstract][Full Text] [Related]
6. Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines.
Gwangwa MV; Joubert AM; Visagie MH
Biol Res; 2019 Mar; 52(1):15. PubMed ID: 30917872
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib.
Hongthong K; Nhukeaw T; Temboot P; Dyson PJ; Ratanaphan A
Heliyon; 2021 Aug; 7(8):e07749. PubMed ID: 34430738
[TBL] [Abstract][Full Text] [Related]
8. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
9. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells.
Greenshields AL; Fernando W; Hoskin DW
Exp Mol Pathol; 2019 Apr; 107():10-22. PubMed ID: 30660598
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12.
Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
[TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines.
Takeshima M; Ono M; Higuchi T; Chen C; Hara T; Nakano S
Cancer Sci; 2014 Mar; 105(3):252-7. PubMed ID: 24397737
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines.
Kim YJ; Pyo JS; Jung YS; Kwak JH
Bioorg Med Chem Lett; 2017 Feb; 27(3):607-611. PubMed ID: 27993518
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways.
Machado VA; Peixoto D; Queiroz MJ; Soares R
J Cell Biochem; 2016 Dec; 117(12):2791-2799. PubMed ID: 27152982
[TBL] [Abstract][Full Text] [Related]
16. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.
Abdullah ML; Hafez MM; Al-Hoshani A; Al-Shabanah O
BMC Complement Altern Med; 2018 Dec; 18(1):321. PubMed ID: 30518369
[TBL] [Abstract][Full Text] [Related]
17. Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
Abedin MR; Powers K; Aiardo R; Barua D; Barua S
Sci Rep; 2021 Apr; 11(1):7347. PubMed ID: 33795712
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
19. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
20. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
